The Opening Bell || What Is The Big Boost To Australia’s COVID-19 Vaccination Program?

• Australia’s vaccination program, COVID-19 vaccine maker Moderna has announced a deal last night to supply 25 million doses to Australia, 10 million of which would be delivered this year.

• In the budget, the Australian government announced an unspecified amount of funding to help create immediate, large-scale manufacturing of messenger RNA drugs in the country.

• Australian shares are set to dip low after stronger-than-expected U.S. inflation data set off further selling of growth stocks on Wall Street amid prospects of tighter monetary policy.

• Tech sector rout is evident during the opening hours. Zip Co, Xero and Afterpay are trading in red territory. On Wednesday, the Australian market witnessed a second consecutive session of a hefty fall of over 1 per cent.

• US stocks slumped, and benchmark Treasury yields jumped after data revealed consumer prices increased by the most in almost 12 years in April 2021. 

• The WTI crude surged by 1.2 per cent to US$66.08 a barrel, the highest close since 11 March.

• The US dollar index rose sharply from the lower level and was up by 0.62 per cent to 90.68.


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK